摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲氧基苯甲酰乙腈 | 35276-83-6

中文名称
2-甲氧基苯甲酰乙腈
中文别名
L-硫代脯氨酸;3-(2-甲氧基苯基)-3-氧代丙腈
英文名称
3-(2-methoxyphenyl)-3-oxopropanenitrile
英文别名
2-methoxybenzoylacetonitrile
2-甲氧基苯甲酰乙腈化学式
CAS
35276-83-6
化学式
C10H9NO2
mdl
MFCD01993554
分子量
175.187
InChiKey
VJOMMMVJTFRJAT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    50.1
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2926909090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302
  • 储存条件:
    室温且干燥

SDS

SDS:282d4e5d1394f3d49fdb42b1d2d9d50b
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Methoxybenzoylacetonitrile
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Methoxybenzoylacetonitrile
CAS number: 35276-83-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H9NO2
Molecular weight: 175.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789)
    摘要:
    Alpha-7 nicotinic acetylcholine receptors (alpha 7 nAChR) are implicated in the modulation of many cognitive functions such as attention, working memory, and episodic memory. For this reason, alpha 7 nAChR agonists represent promising therapeutic candidates for the treatment of cognitive impairment associated with Alzheimer's disease (AD) and schizophrenia. A medicinal chemistry effort, around our previously reported chemical series, permitted the discovery of a novel class of alpha 7 nAChR agonists with improved selectivity, in particular against the alpha 3 receptor subtype and better ADME profile. The exploration of this series led to the identification of 5-(4-acetyl[1,4]diazepan-1-yl)pentanoic acid [5-(4-methoxyphenyl)-1H-pyrazol-3-yl] amide (25, SEN15924, WAY-361789), a novel, full agonist of the alpha 7 nAChR that was evaluated in vitro and in vivo. Compound 25 proved to be potent and selective, and it demonstrated a fair pharmacokinetic profile accompanied by efficacy in rodent behavioral cognition models (novel object recognition and auditory sensory gating).
    DOI:
    10.1021/jm300247y
  • 作为产物:
    描述:
    2'-甲氧基苯乙酮 作用下, 以 乙醚乙醇 为溶剂, 生成 2-甲氧基苯甲酰乙腈
    参考文献:
    名称:
    3-Substituted-(5-arylfuran-2-ylcarbonyl)guanidines as NHE-1 inhibitors
    摘要:
    The C-3 substituents effect on NHE-1 inhibitory activity of (5-arylfuran-2-ylcarbonyl)guanidines, previously identified as potent NHE-1 inhibitors, was investigated. The introduction of amine or alkyl groups at the 3-position of the furan ring, next to the acylguanidine moiety, remarkably improves NHE-1 inhibitory potency. Especially the important finding is that 5-(2,5-dichloro)phenyl and 5-(2-methoxy-5-chloro)phenyl derivatives exhibit high NHE-1 inhibitory activities (IC50 < 0.02 microM) that match those of 3-unsubstituted derivatives.
    DOI:
    10.1016/j.bmcl.2006.12.012
点击查看最新优质反应信息

文献信息

  • [EN] POLYCYCLIC AMIDES AS UBE2K MODULATORS FOR TREATING CANCER<br/>[FR] AMIDES POLYCYCLIQUES UTILISÉS EN TANT QUE MODULATEURS D'UBE2K POUR LE TRAITEMENT DU CANCER
    申请人:BERG LLC
    公开号:WO2021138540A1
    公开(公告)日:2021-07-08
    Provided are compounds of Formula (I) and pharmaceutically acceptable salts and compositions thereof, which are useful for treating conditions associated with modulation of UBE2K.
    提供的是Formula (I)的化合物及其药用盐和组合物,可用于治疗与UBE2K调节相关的疾病。
  • Rh(III)-Catalyzed C–H Activation of Benzoylacetonitriles and Tandem Cyclization with Diazo Compounds to Substituted Benzo[<i>de</i>]chromenes
    作者:Feifei Fang、Chunmei Zhang、Chaofan Zhou、Yazhou Li、Yu Zhou、Hong Liu
    DOI:10.1021/acs.orglett.8b00103
    日期:2018.4.6
    Rh (III)-catalyzed C–H activation of benzoylacetonitriles in coupling with diazo compounds was developed to synthesize diversified substituted benzo[de]chromenes via a formal (4 + 2) cycloaddition with a diazo compound and subsequent tandem (4 + 2) cycloaddition with another diazo compound. Intriguingly, synthesis of substituted benzo[de]chromenes and their decarboxylation products could be realized
    Rh(III)催化与重氮化合物偶合的苯甲酰基乙腈的C–H活化反应是通过与重氮化合物的正式(4 + 2)环加成反应和随后的串联(4 + 2)环加成反应,合成出多种取代的苯并[ de ]色烯。与另一种重氮化合物。有趣的是,通过控制反应条件,可以实现取代苯并[ de ]二甲基苯酮及其脱羧产物的合成。这些反应具有广泛的底物范围,中等至良好的产率,以及较高的区域选择性。
  • Formal [3+2] Annulation of Copper‐Allenylidenes with 3‐Oxo‐3‐Arylpropanenitriles: Synthesis of Tetrasubstituted Furans
    作者:De Zhong、Feng Jiang、Siyong Shen、Lan Wang、Wei Wang、Yongjun Wu、Yumei Xiao、Hongchao Guo
    DOI:10.1002/adsc.202000929
    日期:2020.11.18
    The copper‐catalyzed decarboxylative [3+2] annulation of ethynyl benzoxazinanones with 3‐oxo‐3‐arylpropanenitriles has been developed, producing tetrasubstituted furan derivatives in moderate to high yield. This reaction was generally compatible with a wide range of substrates. Notably, the intermediate copper‐allenylidenes worked as a C2 synthon in the cycloaddition reaction.
    已开发出催化的乙炔基苯并恶嗪酮与3-氧代-3-芳基丙腈的[3 + 2]环化反应,可中等至高收率生产四取代呋喃生物。该反应通常与多种底物相容。值得注意的是,中间体-亚烯基在环加成反应中充当C2合成子。
  • Iridium Diamine Catalyst for the Asymmetric Transfer Hydrogenation of Ketones
    作者:Henar Vázquez-Villa、Stefan Reber、Martin A. Ariger、Erick M. Carreira
    DOI:10.1002/anie.201102732
    日期:2011.9.12
    A simple and very efficient chiral aqua iridium(III) diamine complex leads to excellent enantioselectivities in the asymmetric transfer hydrogenation of various α‐cyano and α‐nitro ketones. The catalyst provides the ortho‐substituted aromatic alcohols with especially high ee values. The diamine ligands can be used directly as chiral ligands; conversion into the corresponding sulfamide is not necessary
    一个简单而高效的手性(III)二胺络合物可在各种α-基和α-硝基酮的不对称转移氢化反应中产生出色的对映选择性。该催化剂可提供具有很高ee值的邻位取代的芳族醇。该二胺配体可直接用作手性配体。不必转化为相应的磺酰胺。
  • [EN] 5-MEMBERED HETEROCYCLE-BASED P38 KINASE INHIBITORS<br/>[FR] INHIBITEURS DE LA KINASE P38 A BASE D'HETEROCYCLES A 5 CHAINONS
    申请人:TRIAD THERAPEUCTICS INC
    公开号:WO2005009973A1
    公开(公告)日:2005-02-03
    Provided are 5-membered heterocycle-based p38 kinase inhibitors. Further provided are pyrazole and imidazole-based p38 kinase, including p38α and p38β kinase, inhibitors. Pharmaceutical compositions containing the compounds are also provided. Methods of use of the compounds and compositions are also provided, including method of treatment, prevention, or amelioration of one or more symptoms of p38 kinase mediated diseases and disorders, including, but not limited to, inflammatory diseases and disorders.
    提供了基于5-成员杂环的p38激酶抑制剂。进一步提供了基于吡唑咪唑的p38激酶抑制剂,包括p38α和p38β激酶。还提供了含有这些化合物的药物组合物。还提供了这些化合物和组合物的使用方法,包括治疗、预防或改善p38激酶介导的疾病和疾病的一个或多个症状的方法,包括但不限于炎症性疾病和疾病。
查看更多